GSK boosts lung cancer portfolio with $10.6 billion Nuvalent takeover

Investing.com Gold reports: GSK boosts lung cancer portfolio with $10.6 billion Nuvalent takeover. Full body text was unavailable at ingest time, so this brief is based on headline context.